HK1022420A1 - The use of homocysteine derivatives for the treatment of bacterial infections. - Google Patents
The use of homocysteine derivatives for the treatment of bacterial infections.Info
- Publication number
- HK1022420A1 HK1022420A1 HK00101298A HK00101298A HK1022420A1 HK 1022420 A1 HK1022420 A1 HK 1022420A1 HK 00101298 A HK00101298 A HK 00101298A HK 00101298 A HK00101298 A HK 00101298A HK 1022420 A1 HK1022420 A1 HK 1022420A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- treatment
- bacterial infections
- homocysteine
- derivatives
- homocysteine derivatives
- Prior art date
Links
- FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical class OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 title abstract 3
- 208000035143 Bacterial infection Diseases 0.000 title 1
- 208000022362 bacterial infectious disease Diseases 0.000 title 1
- 230000002503 metabolic effect Effects 0.000 abstract 2
- 239000002243 precursor Substances 0.000 abstract 2
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT98MI001267A ITMI981267A1 (it) | 1998-06-05 | 1998-06-05 | Uso di derivati dell'omocisteina per la preparazione di farmaci destinati ad inibire l'adesivita'batterica |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1022420A1 true HK1022420A1 (en) | 2000-08-11 |
Family
ID=11380184
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK00101298A HK1022420A1 (en) | 1998-06-05 | 2000-03-31 | The use of homocysteine derivatives for the treatment of bacterial infections. |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0974353B1 (de) |
| KR (1) | KR100676850B1 (de) |
| AT (1) | ATE286728T1 (de) |
| DE (2) | DE974353T1 (de) |
| DK (1) | DK0974353T3 (de) |
| ES (1) | ES2236989T3 (de) |
| HK (1) | HK1022420A1 (de) |
| IT (1) | ITMI981267A1 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT202000016816A1 (it) * | 2020-07-10 | 2022-01-10 | Edmond Pharma Srl | Composizioni comprendenti composti antiossidanti come coadiuvanti nel trattamento di infezioni virali |
| EP4316481A1 (de) | 2022-08-01 | 2024-02-07 | Edmond Pharma S.R.L. | Erdostein, salze, enantiomere oder metabolite davon zur verwendung bei der behandlung von akuten und chronischen schmerzzuständen |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1173441B (it) * | 1984-03-14 | 1987-06-24 | Edmond Pharma Srl | Sali di eritromicina con derivati dell'acido acetico,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono |
-
1998
- 1998-06-05 IT IT98MI001267A patent/ITMI981267A1/it unknown
-
1999
- 1999-05-28 EP EP99110376A patent/EP0974353B1/de not_active Expired - Lifetime
- 1999-05-28 DE DE0974353T patent/DE974353T1/de active Pending
- 1999-05-28 ES ES99110376T patent/ES2236989T3/es not_active Expired - Lifetime
- 1999-05-28 DE DE69923117T patent/DE69923117T2/de not_active Expired - Lifetime
- 1999-05-28 AT AT99110376T patent/ATE286728T1/de not_active IP Right Cessation
- 1999-05-28 DK DK99110376T patent/DK0974353T3/da active
- 1999-06-03 KR KR1019990020431A patent/KR100676850B1/ko not_active IP Right Cessation
-
2000
- 2000-03-31 HK HK00101298A patent/HK1022420A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0974353A3 (de) | 2000-03-08 |
| ES2236989T3 (es) | 2005-07-16 |
| KR20000005879A (ko) | 2000-01-25 |
| DE69923117D1 (de) | 2005-02-17 |
| DE974353T1 (de) | 2000-08-17 |
| ATE286728T1 (de) | 2005-01-15 |
| EP0974353B1 (de) | 2005-01-12 |
| DK0974353T3 (da) | 2005-05-23 |
| ITMI981267A1 (it) | 1999-12-05 |
| DE69923117T2 (de) | 2005-12-29 |
| EP0974353A2 (de) | 2000-01-26 |
| KR100676850B1 (ko) | 2007-01-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR200000129T2 (tr) | Yepyeni spiroazabisiklik heterosiklik bileşikler. | |
| NO996108L (no) | 9-oksinerytromycinderivater | |
| BG103945A (en) | Derivatives of 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a | |
| ATE248837T1 (de) | Chinuclidin-acrylamide | |
| GEP20043269B (en) | Purine Derivatives, Method for Their Production and Composition Containing the Same | |
| BG106586A (en) | Pyrazolopyramidines as therapeutic agents | |
| GEP20043324B (en) | Purine Derivatives | |
| TR200200579T2 (tr) | Amino-tirazolpiridin türevleri. | |
| GB9822450D0 (en) | Medicaments | |
| EE04850B1 (et) | Pürimidiini derivaatide kasutamine ravimi valmistamiseks, mis on ette nähtud HIV nakkuse raviks, ühend, seda sisaldav farmatseutiline kompositsioon, meetod ühendi ja kompositsiooni valmistamiseks ning kombineeritud preparaat kasutamiseks HIV nakku | |
| AP9701041A0 (en) | Pyridylpyrrole compounds. | |
| CA2292359A1 (en) | Novel azalides and methods of making same | |
| DE69720551D1 (de) | Makrozyklische derivate von erythromycin a und b mit 13 ringatomen | |
| AU697679B2 (en) | Treatment of tinnitis using neuroprotective agents | |
| BR0010938A (pt) | Derivados da 13-metil eritromicina | |
| GEP20084437B (en) | Novel lincomycin derivatives possessing antimicrobial activity | |
| AU1277792A (en) | Compositions for topical administration containing fluticasone propionate and oxiconazole or its salts | |
| CA2380455A1 (en) | 9a-azalides with antibacterial activity | |
| MY104109A (en) | Antibacterial 9-deoxo-9a-allyl and propargyl-9a-aza-9a-homoerythromycin a derivatives. | |
| WO2000010998A3 (en) | Pyridone antibiotic with improved safety profile | |
| HK1022420A1 (en) | The use of homocysteine derivatives for the treatment of bacterial infections. | |
| YU46302A (sh) | Supstituisani piroli | |
| NO984651L (no) | Anvendelse av benzonaftalenderivater for fremstilling av medikamenter for behandling av sykdommer i sentralnervesystemet | |
| SE9602262D0 (sv) | New use of derivatives of cystine | |
| AU1673200A (en) | Medicaments for the treatment of lung infections |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PE | Patent expired |
Effective date: 20190527 |